课题基金 / 基金详情

Tufts Clinical and Translational Science Institute

Tufts Clinical and Translational Science Institute
塔夫茨临床与转化科学研究所
批准号:
10622002
负责人:
Harry P. Selker
金额:
$1139.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2030-04-30

项目摘要

项目成果

Harry P. Selker的其他基金

相似基金

相关文献

中文摘要
翻译
塔夫茨CTSI整体项目总结 在其14年的历史中,塔夫茨临床和翻译科学研究所(CTSI)将合作伙伴聚集在一起 和合作者,并发展了促进临床和转化性研究(CTR)的计划和活动 并推进临床和翻译科学(CTS)的创新。我们专注于我们最适合做的事情 基于我们的技能、资源、合作伙伴和机会。因此,我们提供卓越的服务, 资源、教育和指导,并在当地开展对CTS领域做出贡献的创新研究 以及全国范围内。通过这一应用,保留了我们在所有Tuft中集成的重要结构特征 大学,有目的地选择合作伙伴,并坚持我们的基本原则,我们是 很高兴利用我们长期合作伙伴的贡献和贡献,进一步扩大我们的产品和雄心 资产,并增加新合伙人的特殊资产。 随着增长,我们的基本原则没有改变。我们积极支持全方位的 翻译研究,我们实践“广泛参与的团队科学”,我们是积极的合作者, 接受我们作为“外向的CTSA”的角色。我们相信,只有通过拥有系统和流程来 我们将不断评估和改进方法和操作原则,以实现CTR/CTS的卓越。我们 实行包容性沟通,努力促进卫生公平。我们坚持认为,无论工作在哪里进行 在T.5-T4连续体中,CTR必须对潜在的最终健康影响有一个清晰的视线。除了……之外 这些基本原则,在我们所做的一切中,我们条件反射地寻找机会来贡献新的研究 方法:研究方法。新方法和新途径的开发、示范和传播是 我们的工作,不分领域。此外,我们表示,我们相信严格的针对特定角色的全纳教育和 培训是卓越和推进CTR/CTS的基础。 为了服务于这些原则,我们的目标是:总体目标1:利用塔夫茨CTSI的集体影响 通过响应中心的领导力、包容性和协作性来推进CTS并改善公共卫生 文化,以及对计划和研究的持续改进。总体目标2:提供卓越的 教育、培训和指导,为不同的角色和学科量身定做,以培养专家和多样化 CTS劳动力,并在全国范围内共享这些资源。总体目标3:培养广泛参与的团队 科学,在所有利益相关者的积极参与下,促进相关和有影响力的翻译 这是为了保护所有人口的健康,促进健康公平。总体目标4:创建环境、资源和服务以 通过利用塔夫茨CTSI的各种专业知识和资产,刺激和支持全方位的CTS 合伙人。总体目标5:通过开发、示范和传播创新来促进翻译 解决翻译方面的重大障碍,并提供可概括的翻译见解和解决方案。
英文摘要
TUFTS CTSI OVERALL PROJECT SUMMARY Over its 14 years, Tufts Clinical and Translational Science Institute (CTSI) has brought together partners and collaborators and has grown programs and activities to catalyze clinical and translational research (CTR) and to advance innovation in clinical and translational science (CTS). We focus on what we are best suited to do, based on our skills, resources, partners, and opportunities. Thereby, we provide outstanding services, resources, education, and mentorship, and conduct innovative research contributing to the field of CTS, locally and nationally. With this application, retaining our important structural features of integration across all of Tufts University, of having purposefully-selected partners, and adhering to our foundational principles, we are pleased to further grow our offerings and ambitions leveraging our long-standing partners’ contributions and assets and by adding the special assets of new partners. With growth, our foundational principles have not changed. We actively support the full spectrum of translational research, we practice “broadly-engaged team science,” and we are active collaborators, embracing our role as “the extrovert CTSA.” We believe that only by having systems and processes to continually assess and improve methods and operational principles will we achieve CTR/CTS excellence. We practice inclusive communications and work to advance health equity. And we insist that wherever work is on the T.5-T4 continuum, CTR must have a clear line of sight to potential ultimate impact on health. In addition to these foundational principles, in all we do, we reflexively look for opportunities to contribute novel research methods. Development, demonstration, and dissemination of new methods and approaches are hallmarks of our work, regardless of domain. Also, we manifest our belief that rigorous role-specific inclusive education and training are fundamental to excellence and advancing CTR/CTS. In service of these principles, our aims are: Overall AIM 1: Harness the collective impact of Tufts CTSI to advance CTS and improve public health through responsive Hub leadership, an inclusive and collaborative culture, and continuous improvement of programs and research. Overall AIM 2: Provide outstanding education, training, and mentoring, tailored to different roles and disciplines, to develop an expert and diverse CTS workforce, and share these resources nationally. Overall AIM 3: Cultivate broadly-engaged team science, with active inclusion of all stakeholders, to promote relevant and impactful translation for diverse populations and to promote health equity. Overall AIM 4: Create the environment, resources, and services to stimulate and support the full spectrum of CTS by leveraging the diverse expertise and assets of Tufts CTSI partners. Overall AIM 5: Foster translation by developing, demonstrating, and disseminating innovations that address significant translational roadblocks and provide generalizable translational insights and solutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tufts Clinical and Translational Science Institute (Clinical Trial Design Labs Supplement)
  • 批准号:
    10844980
  • 项目类别:
  • 资助金额:
    $97.51万
  • 财政年份:
    2023
  • 负责人:
    Harry P. Selker
  • 依托单位:
Tufts Clinical and Translational Science Institute
  • 批准号:
    9816143
  • 项目类别:
  • 资助金额:
    $13.45万
  • 财政年份:
    2018
  • 负责人:
    Harry P. Selker
  • 依托单位:
Tufts Clinical and Translational Science Institute
  • 批准号:
    10412102
  • 项目类别:
  • 资助金额:
    $966.99万
  • 财政年份:
    2018
  • 负责人:
    Harry P. Selker
  • 依托单位:
Tufts Clinical and Translational Science Institute
  • 批准号:
    10159334
  • 项目类别:
  • 资助金额:
    $943.36万
  • 财政年份:
    2018
  • 负责人:
    Harry P. Selker
  • 依托单位:
海外基金